Bruce E. Reidenberg

Tamper resistant transdermal dosage form

Transdermal buprenorphine dosage regimen for analgesia

Treatment of dependence withdrawal

Transdermal buprenorphine to treat pain in sickle cell crisis

Tamper-resistant transdermal dosage form comprising an active agent component and an adverse agent component at the distal site of the active agent layer

Transdermal buprenorphine dosage regimen for treatment of diarrhea

Preoperative treatment of post operative pain

Transdermal dosage form comprising an active agent component and an adverse agent component at the distal site of the active agent layer and one fluid communication between the surface of the active agent and the adverse agent

DOSIS TRANSDERMICA RESISTENTE A LAS INTERFERENCIAS, QUE COMPRENDE UN COMPONENTE DE AGENTE ACTIVO Y UN COMPONENTE DE AGENTE NOCIVO EN EL SITIO DISTAL DE LA CAPA DEL AGENTE

Treatment of withdrawal